The second webinar in our “Next Era in U.S. Healthcare Policy & Access” series looks at the evolving healthcare policy landscape from a different perspective.

Join us as we explore how U.S. policy changes are impacting health plans, how health plan decision-making needs to adapt, and what this means for biopharma companies. The webinar will feature an engaging panel discussion hosted by Max Hunt, Partner at Trinity Life Sciences, with special guests Stephen George and Matthew Hayes, clinical and actuarial experts at Milliman.

Key Webinar Topics

• How have health plans been adapting in light of recent U.S. policy reform, including Part D redesign introduced in the Inflation Reduction Act (IRA)?
• What key opportunities and challenges do health plans face in the next two to three years? How does this differ across Commercial, MA-PD and PDP offerings?
• How should biopharma companies expect that health plan behavior may change in the coming years?
• What challenges may be posed to driving access to innovative drugs, especially in competitive categories?
• What should biopharma companies do to adapt to these landscape shifts and how can they better understand their health plan customers?